The gastrin and cholecystokinin receptors mediated signaling network: A scaffold for data analysis and new hypotheses on regulatory mechanisms

BMC Systems Biology

Volumn 9, Issue 1, 2015, Pages

  Tripathi, Sushil ^a   Flobak, Åsmund ^a   Chawla, Konika ^a   Baudot, Anaïs ^b   Bruland, Torunn ^a   Thommesen, Liv ^a   Kuiper, Martin ^a   Lægreid, Astrid ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b CNRS   (France)

Author keywords

Cholecystokinin receptor; Gastrin; Map; Model; Modules; Network; Protein protein interaction; Signaling pathway

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; GASTRIN;

ANIMAL; APOPTOSIS; BIOLOGY; INTRACELLULAR SPACE; METABOLISM; PROTEIN ANALYSIS; RAT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GASTRINS; INTRACELLULAR SPACE; PROTEIN INTERACTION MAPPING; RATS; RECEPTOR, CHOLECYSTOKININ B; SIGNAL TRANSDUCTION;

EID: 84937805700     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/s12918-015-0181-z     Document Type: Article

References (90)

1. Rehfeld JF. The New Biology of Gastrointestinal Hormones. Physiol Rev. 1998;78(4):1087-108.
2. Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6(12):936-46.
3. Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev. 2005;6(4):297-306.
4. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci U S A. 1989;86:8968-71.
5. Gukovsky I, Cheng JH, Nam KJ, Lee OT, Lugea A, Fischer L, et al. Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells. Gastroenterology. 2004;126:554-66.
6. Dabrowski A, Grady T, Logsdon CD, Williams JA. Jun kinases are rapidly activated by cholecystokinin in rat pancreas both in vitro and in vivo. J Biol Chem. 1996;271:5686-90.
7. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol. 1973;84:488-95.
8. Witkamp RF. Current and future drug targets in weight management. Pharm Res. 2011;28:1792-818.
9. Varga G, Bálint A, Burghardt B, D'Amato M. Involvement of endogenous CCK and CCK1 receptors in colonic motor function. Br J Pharmacol. 2004;141:1275-84.
10. Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev. 2006;86(3):805-47.
11. Cawston EE, Miller LJ. Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. Br J Pharmacol. 2010;159(5):1009-21.
12. Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol. 2009;60(3):3-21.
13. Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer. 2006;42(6):708-16.
14. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011;39(Database issue):D691-7.
15. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(D1):D109-14.
16. Kaizu K, Ghosh S, Matsuoka Y, Moriya H, Shimizu-Yoshida Y, Kitano H. A comprehensive molecular interaction map of the budding yeast cell cycle. Mol Syst Biol. 2010;6:415.
17. Gloaguen P, Crépieux P, Heitzler D, Poupon A, Reiter E. Mapping the follicle-stimulating hormone-induced signalling networks. Front Endocrinol. 2011;2:45.
18. Oda K, Matsuoka Y, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005;1:2005.0010.
19. Calzone L, Gelay A, Zinovyev A, Radvanyi F, Barillot E. A comprehensive modular map of molecular interactions in RB/E2F pathway. Mol Syst Biol. 2008;4:173.
20. Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, et al. A comprehensive map of the mTOR signaling network. Mol Syst Biol. 2010;6:453.
21. Fink MY, Pincas H, Choi SG, Nudelman G, Sealfon SC. Research Resource: Gonadotropin-Releasing Hormone Receptor-Mediated Signaling Network in L beta T2 Cells: A Pathway-Based Web-Accessible Knowledgebase. Mol Endocrinol. 2010;24(9):1863-71.
22. Mizuno S, Iijima R, Ogishima S, Kikuchi M, Matsuoka Y, Ghosh S, et al. AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease. BMC Syst Biol. 2012;6:52.
23. Patil S, Pincas H, Seto J, Nudelman G, Nudelman I, Sealfon SC. Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Syst Biol. 2010;4:137.
24. Raza S, McDerment N, Lacaze PA, Robertson K, Watterson S, Chen Y, et al. Construction of a large scale integrated map of macrophage pathogen recognition and effector systems. BMC Syst Biol. 2010;4:63.
25. Zhong J, Sharma J, Raju R, Palapetta SM, Prasad TS, Huang TC, et al. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. Database. 2014;2014:bau007.
26. Subbannayya Y, Anuja K, Advani J, Ojha UK, Nanjappa V, George B, et al. A network map of the gastrin signaling pathway. J Cell Commun Signal. 2014;8(2):165-70.
27. Zinovyev A, Viara E, Calzone L, Barillot E. BiNoM: a Cytoscape plugin for manipulating and analyzing biological networks. Bioinformatics. 2008;24(6):876-7.
28. Glaab E, Baudot A, Krasnogor N, Valencia A. Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics. 2010;11:597.
29. Novere NL, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, et al. The systems biology graphical notation. Nat Biotech. 2009;27(8):735-41.
30. Kitano H, Funahashi A, Matsuoka Y, Oda K. Using process diagrams for the graphical representation of biological networks. Nat Biotechnol. 2005;23(8):961-6.
31. Novere NL, Finney A, Hucka M, Bhalla US, Campagne F, Collado-Vides J, et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotech. 2005;23(12):1509-15.
32. Frisch M, Klocke B, Haltmeier M, Frech K. LitInspector: literature and signal transduction pathway mining in PubMed abstracts. Nucleic Acids Res. 2009;37 suppl 2:W135-40.
33. Hoffmann R, Valencia A. A gene network for navigating the literature. Nat Genet. 2004;36(7):664.
34. Matsuoka Y, Ghosh S, Kikuchi N, Kitano H. Payao: a community platform for SBML pathway model curation. Bioinformatics. 2010;26(10):1381-3.
35. Mi H, Thomas P. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol. 2009;563:123-40.
36. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431-2.
37. Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282-4.
38. Souiai O, Becker E, Prieto C, Benkahla A, De Las Rivas J, Brun C. Functional integrative levels in the human interactome recapitulate organ organization. PLoS One. 2011;6(7):e22051.
39. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, et al. International Union of Pharmacology. XXI. Structure, Distribution, and Functions of Cholecystokinin Receptors. Pharmacol Rev. 1999;51(4):745-81.
40. Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol. 1994;266(6):G963-71.
41. Dabrowski A, VanderKuur JA, CarterSu C, Williams JA. Cholecystokinin stimulates formation of Shc-Grb2 complex in rat pancreatic acinar cells through a protein kinase C-dependent mechanism. J Biol Chem. 1996;271(43):27125-9.
42. Dabrowski A, Groblewski GE, Schafer C, Guan KL, Williams JA. Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells. Am J Physiol Cell Physiol. 1997;273(5):C1472-9.
43. Sabbatini ME, Bi Y, Ji B, Ernst SA, Williams JA. CCK activates RhoA and Rac1 differentially through Gaα13 and Gaαq in mouse pancreatic acini. Am J Physiol Cell Physiol. 2010;298(3):C592-601.
44. Duan RD, Williams JA. Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol Gastrointest Liver Physiol. 1994;267(3):G401-8.
45. Paillasse MR, de Medina P, Amouroux G, Mhamdi L, Poirot M, Silvente-Poirot S. Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. J Lipid Res. 2009;50(11):2203-11.
46. Sancho V, Berna MJ, Thill M, Jensen RT. PKCe activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades. Biochim Biophys Acta. 2011;1813(12):2145-56.
47. Quattrone A, Dewaele B, Wozniak A, Bauters M, Vanspauwen V, Floris G, et al. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumours pathogenesis. J Pathol. 2012;228(4):565-74.
48. Wu V, Yang M, McRoberts JA, Ren J, Seensalu R, Zeng N, et al. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem. 1997;272:9037-42.
49. Le Page SL, Bi Y, Williams JA. CCK-A receptor activates RhoA through G alpha 12/13 in NIH3T3 cells. Am J Physiol Cell Physiol. 2003;285:C1197-206.
50. Moustafa A, Sakamoto KQ, Habara Y. A fundamental role for NO-PLC signaling pathway in mediating intracellular Ca2+ oscillation in pancreatic acini. Nitric Oxide Biol Chem. 2011;24:139-50.
51. Cordelier P, Estève JP, Rivard N, Marletta M, Vaysse N, Susini C, et al. The activation of neuronal NO synthase is mediated by G-protein betagamma subunit and the tyrosine phosphatase SHP-2. FASEB J. 1999;13:2037-50.
52. Thorn P, Gerasimenko O, Petersen OH. Cyclic ADP-ribose regulation of ryanodine receptors involved in agonist evoked cytosolic Ca2+ oscillations in pancreatic acinar cells. EMBO J. 1994;13:2038-43.
53. Cosker F, Cheviron N, Yamasaki M, Menteyne A, Lund FE, Moutin M-J, et al. The ecto-enzyme CD38 is a nicotinic acid adenine dinucleotide phosphate (NAADP) synthase that couples receptor activation to Ca2+ mobilization from lysosomes in pancreatic acinar cells. J Biol Chem. 2010;285:38251-9.
54. Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X, et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature. 2009;459:596-600.
55. Gurda GT, Guo L, Lee SH, Molkentin JD, Williams JA. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo. Mol Biol Cell. 2008;19(1):198-206.
56. Lankisch TO, Nozu F, Owyang C, Tsunoda Y. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini. Eur J Cell Biol. 1999;78(9):632-41.
57. Yoshida H, Nozu F, Lankisch TO, Mitamura K, Owyang C, Tsunoda Y. A possible role for Ca(2+)/calmodulin-dependent protein kinase IV during pancreatic acinar stimulus-secretion coupling. Biochim Biophys Acta. 2000;1497(1):155-67.
58. Sinclair NF, Ai W, Raychowdhury R, Bi M, Wang TC, Koh TJ, et al. Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2004;286(6):G992-9.
59. Miyazaki Y, Shinomura Y, Tsutsui S, Zushi S, Higashimoto Y, Kanayama S, et al. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor. Gastroenterology. 1999;116(1):78-89.
60. Sturany S, Van Lint J, Gilchrist A, Vandenheede JR, Adler G, Seufferlein T. Mechanism of Activation of Protein Kinase D2(PKD2) by the CCKB/Gastrin Receptor. J Biol Chem. 2002;277(33):29431-6.
61. Yassin RR, Little KM. Early signalling mechanism in colonic epithelial cell response to gastrin. Biochem J. 1995;311(Pt 3):945-50.
62. He H, Shulkes A, Baldwin GS. PAK1 interacts with beta-catenin and is required for the regulation of the beta-catenin signalling pathway by gastrins. Biochim Biophys Acta. 2008;1783(10):1943-54.
63. Mishra P, Senthivinayagam S, Rana A, Rana B. Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells. J Mol Signal. 2010;5:9.
64. He H, Baldwin GS. Rho GTPases and p21-activated kinase in the regulation of proliferation and apoptosis by gastrins. Int J Biochem Cell Biol. 2008;40(10):2018-22.
65. He H, Yim M, Liu KH, Cody SC, Shulkes A, Baldwin GS. Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by Gastrins. Cell Signal. 2008;20(1):83-93.
66. Guo Y-S, Cheng J-Z, Jin G-F, Gutkind JS, Hellmich MR, Townsend CM. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem. 2002;277:48755-63.
67. von Blume J, Knippschild U, Dequiedt F, Giamas G, Beck A, Auer A, et al. Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2. EMBO J. 2007;26(22):4619-33.
68. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-504.
69. Seva C, Kowalski-Chauvel A, Daulhac L, Barthez C, Vaysse N, Pradayrol L. Wortmannin-Sensitive Activation of p70S6-Kinase and MAP-Kinase by the G Protein-Coupled Receptor, G/CCKB. Biochem Biophys Res Commun. 1997;238(1):202-6.
70. Kikani CK, Dong LQ, Liu F. "New"-clear functions of PDK1: beyond a master kinase in the cytosol? J Cell Biochem. 2005;96(6):1157-62.
71. Pradeep A, Sharma C, Sathyanarayana P, Albanese C, Fleming JV, Wang TC, et al. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene. 2004;23(20):3689-99.
72. Steigedal TS, Bruland T, Misund K, Thommesen L, Laegreid A. Inducible cAMP early repressor suppresses gastrin-mediated activation of cyclin D1 and c-fos gene expression. Am J Physiol Gastrointest Liver Physiol. 2007;292(4):G1062-9.
73. Dehez S, Daulhac L, Kowalski-Chauvel A, Fourmy D, Pradayrol L, Seva C. Gastrin-induced DNA synthesis requires p38-MAPK activation via PKC/Ca2+ and Src-dependent mechanisms. FEBS Lett. 2001;496(1):25-30.
74. Dehez S, Bierkamp C, Kowalski-Chauvel A, Daulhac L, Escrieut C, Susini C, et al. c-Jun NH2-terminal Kinase Pathway in Growth-promoting Effect of the G Protein-coupled Receptor Cholecystokinin B Receptor: A Protein Kinase C/Src-dependent-Mechanism. Cell Growth Differ. 2002;13(8):375-85.
75. Stepan VM, Dickinson CJ, del Valle J, Matsushima M, Todisco A. Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin. Am J Physiol. 1999;276(6 Pt 1):G1363-72.
76. Zimmermann S, Moelling K. Phosphorylation and Regulation of Raf by Akt (Protein Kinase B). Science. 1999;286(5445):1741-4.
77. Bierkamp C, Kowalski-Chauvel A, Dehez S, Fourmy D, Pradayrol L, Seva C. Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cells. Oncogene. 2002;21(50):7656-70.
78. Mishra P, Senthivinayagam S, Rangasamy V, Sondarva G, Rana B. Mixed Lineage Kinase-3/JNK1 Axis Promotes Migration of Human Gastric Cancer Cells following Gastrin Stimulation. Mol Endocrinol. 2010;24(3):598-607.
79. Yu H-G, Nam J-O, Miller NLG, Tanjoni I, Walsh C, Shi L, et al. p190RhoGEF (Rgnef) Promotes Colon Carcinoma Tumor Progression via Interaction with Focal Adhesion Kinase. Cancer Res. 2011;71(2):360-70.
80. Ding J, Yu JP, Li D, Yu HG, Luo HS, Wei WZ. Effect of gastrin on invasiveness of human colon cancer cells. Zhonghua zhong liu za zhi. 2005;27(4):213-5.
81. Fjeldbo CS, Bakke I, Erlandsen SE, Holmseth J, Laegreid A, Sandvik AK, et al. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. Am J Physiol Gastrointest Liver Physiol. 2012;302(1):G21-33.
82. Ramamoorthy S, Stepan V, Todisco A. Intracellular mechanisms mediating the anti-apoptotic action of gastrin. Biochem Biophys Res Commun. 2004;323(1):44-8.
83. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks. Bioinformatics. 2005;21(16):3448-9.
84. Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell. 2012;149(4):780-94.
85. Jun Cao J-PY, Chao-Hong L, Lan Z, Hong-Gang Y. Effects of gastrin 17 on β-catenin/Tcf-4 pathway in Colo320WT colon cancer cells. World J Gastroenterol. 2006;12(46):7482-7.
86. Clarke PA, Dickson JH, Harris JC, Grabowska A, Watson SA. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res. 2006;66(7):3504-12.
87. Trulsson LM, Gasslander T, Svanvik J. Cholecystokinin-8-induced hypoplasia of the rat pancreas: influence of nitric oxide on cell proliferation and programmed cell death. Basic Clin Pharmacol Toxicol. 2004;95(4):183-90.
88. Tiger CF, Krause F, Cedersund G, Palmer R, Klipp E, Hohmann S, et al. A framework for mapping, visualisation and automatic model creation of signal-transduction networks. Mol Syst Biol. 2012;8:578.
89. Leach SM, Tipney H, Feng W, Baumgartner WA, Kasliwal P, Schuyler RP, et al. Biomedical discovery acceleration, with applications to craniofacial development. PLoS Comput Biol. 2009;5(3):e1000215.
90. Gitter A, Carmi M, Barkai N, Bar-Joseph Z. Linking the signaling cascades and dynamic regulatory networks controlling stress responses. Genome Res. 2012;23(2):365-76.